Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients

Melissa Kerkhof, Pauline L. Tans, Rogier E. Hagenbeek, Geert J. Lycklama À Nijeholt, Finn K. Holla, Tjeerd J. Postma, Chiara S. Straathof, Linda Dirven, Martin Jb Taphoorn, Maaike J. Vos

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

AIM: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in glioblastoma patients during treatment with temozolomide chemoradiation.
Original languageEnglish
Pages (from-to)297-306
JournalCNS Oncology
Volume6
Issue number4
DOIs
Publication statusPublished - 2017

Cite this